MART-1/GP100/Tyrosinase peptide vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MART-1/GP100/Tyrosinase peptide vaccine, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase [Phase 2]